KRAS and colonic neoplasm: In line with our previous observation, synergistic activity was only observed in HT-29 and RKO cell lines, which have wild-type KRAS genes, and not in HCT116, DLD-1, and other colon cancer cell lines with mutant KRAS genes (Fig. 3A; Table S3; data not shown).